AAAAAA

   
Results: 1-12 |
Results: 12
Cytochrome P450 involvement in the biotransformation of cisapride and racemic norcisapride in vitro: Differential activity of individual human CYP3A isoforms
Authors: Pearce, RE Gotschall, RR Kearns, GL Leeder, JS
Citation: Re. Pearce et al., Cytochrome P450 involvement in the biotransformation of cisapride and racemic norcisapride in vitro: Differential activity of individual human CYP3A isoforms, DRUG META D, 29(12), 2001, pp. 1548-1554
Pharmacogenetics and pharmacogenomics
Authors: Leeder, JS
Citation: Js. Leeder, Pharmacogenetics and pharmacogenomics, PED CLIN NA, 48(3), 2001, pp. 765
Cytochrome P4502C9 (CYP2C9) allele frequencies in canadian native indian and inuit populations
Authors: Gaedigk, A Casley, WL Tyndale, RF Sellers, EM Jurima-Romet, M Leeder, JS
Citation: A. Gaedigk et al., Cytochrome P4502C9 (CYP2C9) allele frequencies in canadian native indian and inuit populations, CAN J PHYSL, 79(10), 2001, pp. 841-847
Combined phenotypic assessment of CYP1A2, CYP2C19, CYP2D6, CYP3A, N-acetyltransferase-2, and xanthine oxidase with the "Cooperstown cocktail"
Authors: Streetman, DS Bleakley, JF Kim, JS Nafziger, AN Leeder, JS Gaedigk, A Gotschall, R Kearns, GL Bertino, JS
Citation: Ds. Streetman et al., Combined phenotypic assessment of CYP1A2, CYP2C19, CYP2D6, CYP3A, N-acetyltransferase-2, and xanthine oxidase with the "Cooperstown cocktail", CLIN PHARM, 68(4), 2000, pp. 375-383
Acetaminophen intoxication during treatment: What you don't know can hurt you
Authors: Kearns, GL Leeder, JS Wasserman, GS
Citation: Gl. Kearns et al., Acetaminophen intoxication during treatment: What you don't know can hurt you, CLIN PEDIAT, 39(3), 2000, pp. 133-144
Optimization of cytochrome P4502D6 (CYP2D6) phenotype assignment using a genotyping algorithm based on allele frequency data
Authors: Gaedigk, A Gotschall, RR Forbes, NS Simon, SD Kearns, GL Leeder, JS
Citation: A. Gaedigk et al., Optimization of cytochrome P4502D6 (CYP2D6) phenotype assignment using a genotyping algorithm based on allele frequency data, PHARMACOGEN, 9(6), 1999, pp. 669-682
Limitations of dextromethorphan N-demethylation as a measure of CYP3A activity
Authors: Kashuba, ADM Nafziger, AN Kearns, GL Leeder, JS Gotschall, R Gaedigk, A Bertino, JS
Citation: Adm. Kashuba et al., Limitations of dextromethorphan N-demethylation as a measure of CYP3A activity, PHARMACOGEN, 9(4), 1999, pp. 453-462
Cytochrome P450 3A - Ontogeny and drug disposition
Authors: de Wildt, SN Kearns, GL Leeder, JS van den Anker, JN
Citation: Sn. De Wildt et al., Cytochrome P450 3A - Ontogeny and drug disposition, CLIN PHARMA, 37(6), 1999, pp. 485-505
Glucuronidation in humans - Pharmacogenetic and developmental aspects
Authors: de Wildt, SN Kearns, GL Leeder, JS van den Anker, JN
Citation: Sn. De Wildt et al., Glucuronidation in humans - Pharmacogenetic and developmental aspects, CLIN PHARMA, 36(6), 1999, pp. 439-452
Potent inhibition of cytochrome P-450 2D6-mediated dextromethorphan O-demethylation by terbinafine
Authors: Abdel-Rahman, SM Marcucci, K Boge, T Gotschall, RR Kearns, GL Leeder, JS
Citation: Sm. Abdel-rahman et al., Potent inhibition of cytochrome P-450 2D6-mediated dextromethorphan O-demethylation by terbinafine, DRUG META D, 27(7), 1999, pp. 770-775
Dose dependency of dextromethorphan for cytochrome P450 2D6 (CYP2D6) phenotyping
Authors: Streetman, DS Ellis, RE Nafziger, AN Leeder, JS Gaedigk, A Gotschall, R Kearns, GL Bertino, JS
Citation: Ds. Streetman et al., Dose dependency of dextromethorphan for cytochrome P450 2D6 (CYP2D6) phenotyping, CLIN PHARM, 66(5), 1999, pp. 535-541
Investigation of terbinafine as a CYP2D6 inhibitor in vivo
Authors: Abdel-Rahman, SM Gotschall, RR Kauffman, RE Leeder, JS Kearns, GL
Citation: Sm. Abdel-rahman et al., Investigation of terbinafine as a CYP2D6 inhibitor in vivo, CLIN PHARM, 65(5), 1999, pp. 465-472
Risultati: 1-12 |